NTT-COMMUNICATIONS
28.9.2020 08:02:09 CEST | Business Wire | Press release
NTT Communications Corporation (NTT Com), the ICT solutions and international communications business within the NTT Group (TOKYO:9432), announced today that beginning October 1 it will collaborate with the International Data Spaces Association (IDSA)1 in a demonstration test as the first phase of contributing to the development of a secure, global data-management platform2 that assures interoperability between data platforms built and managed in countries worldwide.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200927005006/en/
The test environment for sharing highly confidential data securely will include IDS Connectors3 , the core technology of GAIA-X4 , a federated data infrastructure for Europe, and NTT Com’s Things Cloud® IoT platform and Smart Data Platform (SDPF)5 , the later incorporating Data Trust®6 policies. The demonstration, in addition to assessing the practicality and operability of a new structure for appropriately controlling the access rights of each data based on related laws and contracts, will shed new light on the requirements, etc. of platforms designed for international data management. The results are expected to lead to the establishment of global data management platforms that smoothly link local data platforms in countries across the globe.
In the demonstration, a test environment will be built to test various cases of international data sharing, such as remote monitoring of machines overseas, etc., to verify the practicality and operability of data sharing. Initially, in collaboration with the NTT Software Innovation Center,7 IDS Connector and SDPF will be deployed in a test environment in Japan to test system interoperability and the management of specific data-usage rights. The test environment in Japan will then be connected to IDSA’s test environment in Germany and a separate test environment at the Swiss nonprofit Switzerland Innovation Park Biel/Bienne8 to test the system’s practicality and operability in controlling data access rights internationally via NTT Com’s networks.
Thereafter, NTT Com will proceed with further verification and testing by applying the current test’s findings in a test operation environment (test bed), aiming to verify the interoperability of various hardware and software using the IDS Connector. The new global data management platform will be jointly developed by Japanese and overseas companies and organizations. At the same time, NTT Com will determine concrete requirements for the platform together with various organizations and companies active in Japan and overseas, including the Robot Revolution & Industrial IoT Initiative.9 Going forward, NTT Com hopes to support the formulation of basic specifications through public-private-academic collaboration. Ultimately, NTT Com aims to contribute to the realization of a smart world by developing and providing a platform for broad sharing and usage of data in wide-ranging fields worldwide.
Technologies for IoT, artificial intelligence and data utilization are increasingly being applied in diverse fields, including manufacturing, logistics, transportation, medical care, energy, cities and government. To facilitate advanced, multipurposed data use, systems are needed to ensure the safe, reliable exchange of data among industries, businesses and countries. Simultaneously, the rights of data providers and users must be protected and observed by managing when, where, who, why and under what conditions specific data can be used. Currently, legal systems and technologies are being developed worldwide to create such data infrastructure. Eventually, data exchange in international business may require compliance with data-infrastructure specifications according to the laws and regulations of relevant countries.
1 |
The International Data Spaces Association (IDSA), originating in Europe, has defined a reference architecture and a formal standard to be used for creating and operating virtual data spaces. The International Data Spaces (IDS) Architecture is based on commonly accepted data governance models facilitating secure exchange and easy linkage of data within business ecosystems. IDSA counts over 120 member organizations from 21 countries. |
2 |
Global data-management platform is a function for mutually linking data platforms across borders so that each country can internationally distribute data safely, fairly and appropriately while protecting national assets and human rights. |
3 |
IDS Connector provided by IDSA is the core element of a data ecosystem designed to facilitate the secure exchange of data between trusted parties. Deployed in the GAIA-X infrastructure as well as in clouds, on edge computers or on devices, etc. that send and receive data, it provides settings for managing access to specific data based on laws and contracts. |
4 |
GAIA-X is an initiative announced by the German and French governments in October 2019 to build decentralized data infrastructure for data sharing and utilization protected by European data laws. |
5 |
Smart Data Platform (SDPF) is NTT Com’s next-generation platform that offers comprehensive, one-stop functions for corporate digital transformation (DX). |
6 |
DATA Trust® is a registered trademark of Nippon Telegraph and Telephone Corporation (NTT). |
7 |
The NTT Software Innovation Center is an NTT laboratory engaged in researching and developing IT infrastructure technologies, such as DX acceleration, software infrastructure, AI infrastructure and next-generation computers, that are becoming important infrastructure. |
8 |
Switzerland Innovation Park Biel/Bienne is a Swiss private nonprofit organization that carries out and supports primarily industry-oriented applied research and development. |
9 |
The Robot Revolution & Industrial IoT Initiative is a private organization established in 2015 at the initiative of the Japanese government to facilitate the use of industrial IoT, robots, etc. NTT Com has been active as the secretariat of the Global Data Management Platform Sub-Working group since October 2019. |
About NTT Communications
NTT Communications solves the world's technology challenges by helping enterprises overcome complexity and risk in their ICT environments with managed IT infrastructure solutions. These solutions are backed by our worldwide infrastructure, including industry leading, global tier-1 public and private networks reaching over 190 countries/regions, and more than 500,000m2
of the world's most advanced data center facilities. Our global professional services teams provide consultation and architecture for the resiliency and security required for your business success, and our scale and global capabilities in technology world are unsurpassed. Combined with NTT Ltd., NTT Data, and NTT DOCOMO, we are NTT Group.
www.ntt.com
| Twitter@NTT Com
| Facebook@NTT Com
| LinkedIn@NTT Com
View source version on businesswire.com: https://www.businesswire.com/news/home/20200927005006/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom